Skip to main content

Wellington Management — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

278
Companies
$59.2B
Total invested
$270.5M
Avg. check
66
Industries
Biotechnology 9Therapeutics 8Health Care 8Medical 5Software 5Pharmaceutical 4+60 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 49–72 of 278
Scribe Therapeutics
June 2026

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

Biotechnology · Alameda$25.0M Grant
Moderna
June 2026

Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.

Biotechnology · Cambridge$50.0M Grant
Current
June 2026

Current is a leading consumer fintech banking platform transforming financial access for everyday Americans.

Banking · New York$80.0M Series E
Scale
June 2025

Scale AI provides a data-oriented platform that assists in the development of AI applications.

Agentic AI · San FranciscoCorporate Round
Meati
May 2024

Meati Foods is a consumer goods company that provides fungi-based meat alternatives to everyone.

Alternative Protein · Boulder$100.0M Series C
Kin Insurance
May 2026

Kin Insurance is a direct-to-consumer digital insurance provider that enhances convenience and customization in coverage options.

Consumer · Chicago$335.0M Debt Financing
Allena Pharmaceuticals
May 2022

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.

Biotechnology · Newton$2.8M Post-IPO Equity
CARGO Therapeutics
May 2024

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

Biotechnology · San Mateo$110.0M Post-IPO Equity
Apogee Therapeutics
May 2026

Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.

Biotechnology · San Francisco$1.3B Post-IPO Debt
Omada Health
May 2025

Omada Health is a digital behavioral medicine company that helps members change their mindsets to improve health and build lasting change.

Health Care · San FranciscoSecondary Market
FalconX
May 2025

FalconX is a digital assets prime brokerage providing trading, financing, and custody services.

Cryptocurrency · San MateoDebt Financing
Peloton
May 2024

Peloton is an interactive fitness platform reinventing fitness with live and on-demand boutique studio classes.

Cycling · New York$300.0M Post-IPO Debt
Warby Parker
May 2025

Warby Parker is a lifestyle brand that offers designer eyewear while being a socially conscious business.

E-Commerce · New York$75.0M Post-IPO Equity
Porch Group
May 2025

Porch Group is a vertical software platform for residential environments.

Home Improvement · Seattle$134.0M Post-IPO Debt
SpotOn
May 2022

SpotOn provides mobile payment technology and a management system for restaurants and small businesses.

Mobile Payments · San Francisco$300.0M Series F
Boundless Bio
May 2023

Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.

Biotechnology · La Jolla$100.0M Series C
Acrivon Therapeutics
April 2024

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

Biotechnology · Cambridge$130.0M Post-IPO Equity
Obsidian Therapeutics
April 2024

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

Biotechnology · Cambridge$160.5M Series C
WeWork
April 2024

WeWork is a platform for creators that transforms buildings into dynamic environments for creativity, focus, and collaboration.

Commercial Real Estate · New York$450.0M Post-IPO Equity
Arcadia
April 2024

Arcadia is the global utility data and energy solutions platform.

Charging Infrastructure · Washington$50.0M Series E
Span
March 2026

Span develops residential energy storage devices that provide renewable electricity and charging services for electric vehicles.

Energy · San Francisco$75.0M Corporate Round
Pinterest
March 2026

Pinterest is a visual bookmarking tool for saving and discovering creative ideas.

Internet · San Francisco$1.0B Post-IPO Debt
Zenas BioPharma
March 2026

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Biopharma · Waltham$100.0M Post-IPO Equity
Heartflow
March 2025

Heartflow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.

Artificial Intelligence (AI) · Mountain View$98.0M Convertible Note

Where Wellington Management invests

Biotechnology9
Therapeutics8
Health Care8
Medical5
Software5
Pharmaceutical4

About Wellington Management's portfolio

How many companies has Wellington Management invested in?▸

Wellington Management has invested in 278 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Wellington Management invest in?▸

Wellington Management's top investment sectors include Biotechnology, Therapeutics, Health Care, Medical, Software. The firm invests across 66 different industry categories.

What is Wellington Management's largest investment?▸

Among tracked funding rounds, Apogee Therapeutics received $1.3B in a Post-IPO Debt round. Wellington Management's total known invested capital is $59.2B.

What is the average investment size for Wellington Management?▸

Wellington Management's average investment size is $270.5M across its portfolio of 278 companies.

What are Wellington Management's most recent investments?▸

Recent Wellington Management portfolio additions include Scribe Therapeutics, Moderna, Current, Scale, Meati. These companies were founded in 2020 or later.

Reach the founders behind these 278 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →